Dan‐Arin Silasi

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Journal of Clinical Oncology · 2018 · 525 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

Ayesha B. Alvero, Rui Chen, Han‐Hsuan Fu et al. · Cell Cycle · 2009 · 500 citations · Full text

Medicine, Cell Biology, Oncology +17

TLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer

Michael Kelly, Ayesha B. Alvero, Rui Chen et al. · Cancer Research · 2006 · 490 citations

Life Sciences, Immunology, Oncology +17

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

Siming Zhao, Murim Choi, John D. Overton et al. · Proceedings of the National Academy of Sciences · 2013 · 337 citations · Full text

Medicine, Genetics, Oncology +17

Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells

Ryan Chen, Ayesha B. Alvero, Dan‐Arin Silasi et al. · Oncogene · 2008 · 293 citations · Full text

Medicine, Molecular Biology, Oncology +13